Here we report an analysis of the expression of two novel putative protein biomarkers, FABP7 and HMGCS2, in breast lesions undergoing apocrine differentiation: from benign apocrine metaplasia to invasive apocrine carcinoma. This evidence concerns the gene HMGCS2 and apocrine adenocarcinoma.